In conclusion, our analysis revealed a significant association between lowered MYO1C protein level and endometrial carcinogenesis and also indicated that reduced MYO1C levels is equally important in early as well as late tumor stages, suggesting an important role for MYO1C in all stages of endometrial carcinogenesis. The gene discussed is MYO1C; the disease is neoplasm.